9 METERS BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On April 5, 2023, 9 Meters Biopharma, Inc. issued a press release announcing receipt of a written response from the U.S. Food and Drug Administration on the request for a Type B pre-IND (Investigational New Drug) meeting on the planned pre-clinical development of NM-136 for the treatment of obesity. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



  Exhibit No.  Description
  Exhibit 99.1   Press Release dated April 5, 2023.

  Exhibit 104  Cover Page Interactive Data File (embedded within the Inline XBRL
               document).

© Edgar Online, source Glimpses